NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,749,909 | +6.8% | 17,180 | +5.8% | 0.15% | +13.5% |
| Q2 2023 | $1,638,431 | +5.4% | 16,241 | -3.8% | 0.13% | -7.0% |
| Q1 2023 | $1,553,839 | -49.8% | 16,890 | -50.5% | 0.14% | -46.6% |
| Q4 2022 | $3,097,181 | -12.1% | 34,140 | -26.3% | 0.27% | -23.4% |
| Q3 2022 | $3,523,000 | -15.1% | 46,348 | -5.6% | 0.35% | -16.1% |
| Q2 2022 | $4,150,000 | -9.0% | 49,099 | -5.5% | 0.42% | +4.2% |
| Q1 2022 | $4,560,000 | -9.6% | 51,969 | -9.9% | 0.40% | +7.2% |
| Q4 2021 | $5,045,000 | +4.8% | 57,672 | -2.0% | 0.37% | -6.0% |
| Q3 2021 | $4,814,000 | -9.3% | 58,871 | +1.2% | 0.40% | -9.2% |
| Q2 2021 | $5,309,000 | +4.1% | 58,182 | -2.5% | 0.44% | -7.0% |
| Q1 2021 | $5,098,000 | +128.5% | 59,645 | +144.1% | 0.47% | +56.1% |
| Q2 2019 | $2,231,000 | -52.9% | 24,437 | -50.4% | 0.30% | -9.9% |
| Q1 2019 | $4,734,000 | +98.2% | 49,232 | +76.9% | 0.33% | +92.0% |
| Q4 2018 | $2,388,000 | – | 27,832 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |